1. Raghavendra, Agepati S, Gonugunta, Vijay K, Christmann, Alexander, Grill, Erwin. 2010. ABA perception and signalling. In Trends in plant science, 15, 395-401. doi:10.1016/j.tplants.2010.04.006. https://pubmed.ncbi.nlm.nih.gov/20493758/
2. Li, Huizi, Liu, Jin, Lai, Jie, Zhang, Tong, Gu, Qiuping. 2024. The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC. In Journal of translational medicine, 22, 537. doi:10.1186/s12967-024-05324-2. https://pubmed.ncbi.nlm.nih.gov/38844969/
3. Elavarasu, Santhosh Mudipalli, Vasudevan, Karthick, Sasikumar, K, Doss C, George Priya. 2025. The role of ABI2 in modulating nuclear proteins: Therapeutic implications for NUP54 and NUP153 in TNBC. In Advances in protein chemistry and structural biology, 143, 97-115. doi:10.1016/bs.apcsb.2024.09.011. https://pubmed.ncbi.nlm.nih.gov/39843146/
4. Kang, Gyeoung Jin, Park, Jung Ho, Kim, Hyun Ji, Rho, Seung Bae, Lee, Chang Hoon. 2022. PRR16/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 Kinase. In Biomolecules & therapeutics, 30, 340-347. doi:10.4062/biomolther.2022.066. https://pubmed.ncbi.nlm.nih.gov/35719027/
5. Ergun, Sercan, Gunes, Sezgin, Buyukalpelli, Recep, Aydin, Oguz. 2020. Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study. In International journal of experimental pathology, 101, 87-95. doi:10.1111/iep.12349. https://pubmed.ncbi.nlm.nih.gov/32496656/
6. Huang, Jing, Qin, You, Yang, Chensu, Jin, Honglin, Yang, Kunyu. 2020. Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling. In Aging, 12, 340-358. doi:10.18632/aging.102618. https://pubmed.ncbi.nlm.nih.gov/31907338/
智鼠故事 
